InvestorsHub Logo
Followers 18
Posts 3473
Boards Moderated 0
Alias Born 06/05/2007

Re: monentum2play post# 64052

Thursday, 06/09/2016 10:52:08 AM

Thursday, June 09, 2016 10:52:08 AM

Post# of 726327
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 (NYM)
This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified March 2016 by Jonsson Comprehensive Cancer Center
Sponsor:
Jonsson Comprehensive Cancer Center
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT02775292
First received: May 13, 2016
Last updated: NA
Last verified: March 2016
History: No changes posted

Does this mean anything? This is with Kite!! Has not started yet?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News